Rigenera - HBW

Rigenera - HBW is an Italian biotechnology company founded in 2013, specializing in tissue regeneration technology. The company’s core innovation is the Rigenera® technology, a patented system that transforms small tissue biopsies into micrografts. These micrografts are injected to promote natural tissue regeneration through minimally invasive procedures. The flagship product is a disposable, sterile EU Class IIa medical device that prepares micrografts in about 30 minutes, requiring no special patient preparation or recovery time. This technology is utilized in various medical fields, including dermatology, orthopedics, wound care, plastic surgery, and oral and maxillofacial surgery. Rigenera - HBW focuses on enhancing patient outcomes by reactivating natural healing processes, which can lead to reduced hospital stays and fewer outpatient visits. The company is led by a team of experts dedicated to research and development, regulatory compliance, and quality control. Rigenera - HBW primarily serves medical professionals and specialists, emphasizing its commitment to advanced regenerative medicine solutions.

• Employees14
• Founded2013